Does Novo Nordisk A/S (Class B) (NOVOB.XCSE) pay a dividend?
Novo Nordisk A/S (Class B) (NOVOB.XCSE) has never paid a dividend. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does Novo Nordisk A/S (Class B) (NOVOB.XCSE) pay a dividend?+
No. Novo Nordisk A/S (Class B) (NOVOB.XCSE) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.
How does Novo Nordisk A/S (Class B) return cash to shareholders?+
It largely does not. Novo Nordisk A/S (Class B) pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.
Held by ETFs
NOVOB.XCSE is in 151 US ETFs. The largest of them, with NOVOB.XCSE's weight in each:
Vanguard Total International Stock ETFVXUS0.27%of the fund
iShares Core MSCI EAFE ETFIEFA0.49%of the fund
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NOVOB.XCSE
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.